May 14, 2020 / 11:18 AM / 13 days ago

BRIEF-Prevail Therapeutics Posts Q1 Loss Per Share of $0.56

May 14 (Reuters) - Prevail Therapeutics Inc:

* PREVAIL THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

* Q1 LOSS PER SHARE $0.56

* Q1 EARNINGS PER SHARE ESTIMATE $-0.50 — REFINITIV IBES DATA

* CASH AND CASH EQUIVALENTS WERE $149.6 MILLION AS OF MARCH 31, 2020, AS COMPARED TO $168.1 MILLION AS OF DECEMBER 31, 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below